Overall survival prediction and risk stratification for advanced EGFR-mutant lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors

Authors

Publication Details

Journal
BMC Pulmonary Medicine
Published
2026-10-27
DOI
https://doi.org/10.1186/s12890-026-04853-4
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Overall survival prediction and risk stratification for advanced EGFR-mutant lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors

Jianping Zhong, Yujin Yin, Wenjian Tang, Yuan Kang et al.
2 links
BMC Pulmonary Medicine
Lung Cancer Treatments and Mutations
article

Overall survival prediction and risk stratification for advanced EGFR-mutant lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors

Jianping Zhong, Yujin Yin, Wenjian Tang, Yuan Kang, Shuhua Luo, Zhiqiang Zhang, Jiawei Feng, Junyuan Zhong
article en

Abstract

No abstract available for this paper.
BMC Pulmonary Medicine
Good health and well-being
Openalex Percentile: Top 12%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Overall survival prediction and risk stratification for advanced EGFR-mutant lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors — Jianping Zhong, Yujin Yin, et al. · BMC Pulmonary Medicine (2026) | TGRS Research Map | TGRS